SEC Form 4/A · accession 0001615774-16-007208
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Michal Votruba
Director
Period of report
Apr 5, 2016
Accepted (ET)
Sep 15, 2016 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per shareF1 | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On April 7, 2016, the Reporting Person mistakenly filed a Form 4 reporting a grant and issuance of 250,000 shares of common stock, par value $0.001 per share ("Common Stock"), of MYnd Analytics, Inc. (the "Issuer"), by the Issuer to the Reporting Person on April 5, 2016. The 250,000 shares were instead granted and issued to RSJ Private Equity investicni fond s promennym zakladnim kapitalem, A.S. ("RSJ Private Equity"), of which the Reporting Person is an employee, pursuant to an arrangement between RSJ Private Equity and the Reporting Person. As of April 7, 2016, the Reporting Person beneficially owned no shares of Common Stock of the Issuer.